U.S. Blood Group Typing Market Report Probes the USD Million Size, Share, Growth Report and Future Analysis by 2033

Key Insights

The U.S. Blood Group Typing Market size was valued at USD 611.0 USD Million in 2023 and is projected to reach USD 1000.55 USD Million by 2032, exhibiting a CAGR of 7.3 % during the forecast period. Blood group typing - a key diagnostic procedure that looks at the individual's blood group antigens with ABO being the main ones and the Rhesus factor being a very important one too. This is important for blood transfusions, organ transplants, and prenatal care. One of the ways tests are conducted is serological tests, molecular methods, and blood bank automation. Main systems include ABO and RhD, while subsystems include A1, A2, B, and O. US market trends indicate that in the future the demand for fast, automated, and cost-effective blood typing technologies which will be pushed by many factors such as the increase of chronic diseases, the number of blood transfusion and also advancements in healthcare infrastructure. The Empathize technologies simplify blood typing for patients and have meaning for both patient safety and healthcare productivity.

U.S. Blood Group Typing Trends

• Rising prevalence of transfusion-transmitted infections
• Growing awareness of personalized medicine
• Increasing healthcare expenditure
• Technological advancements in blood typing methods
• Government initiatives to promote safe blood transfusion practices

Driving Forces: What's Propelling the U.S. Blood Group Typing Market

• Technological Advancements Fueling Efficiency and Accuracy: The U.S. blood group typing market is experiencing rapid growth driven by significant advancements in serological and molecular testing methodologies. Innovations such as multiplex polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarrays offer faster turnaround times, higher throughput, and improved accuracy in identifying blood groups, leading to enhanced patient safety and streamlined workflows in blood banks and transfusion services. These technologies also facilitate the detection of rare blood groups and antigens, improving the matching process for challenging transfusions.
• Personalized Medicine and Precision Transfusion: The increasing focus on personalized medicine is a key driver. Precise blood group typing is paramount to ensuring compatibility in transfusions, minimizing the risk of adverse reactions, and optimizing patient outcomes. This personalized approach extends beyond simple ABO and Rh typing to include the identification of other clinically significant blood group antigens, leading to better patient stratification and tailored transfusion strategies.
• Stringent Regulatory Landscape and Quality Standards: The U.S. blood banking industry operates under a rigorous regulatory framework, including the Clinical Laboratory Improvement Amendments (CLIA) and the AABB Standards for Blood Banks and Transfusion Services. These regulations mandate the use of accurate and reliable blood typing methods, driving the adoption of advanced technologies and fostering a culture of quality and safety within the industry. Compliance requirements incentivize the use of automated systems and advanced quality control measures, contributing to market growth.
• Rising Prevalence of Blood-Related Diseases and Transfusion Demand: An increasing prevalence of blood-related diseases and disorders, coupled with an aging population requiring more frequent transfusions, is fueling the demand for reliable and efficient blood group typing. This necessitates a robust and scalable infrastructure capable of handling larger volumes of tests with consistent accuracy and speed.

Challenges and Restraints in the U.S. Blood Group Typing Market

• Cost and accessibility: High costs of advanced blood typing technologies may limit their widespread adoption in certain settings.
• Labor-intensive processes: Traditional serology methods are labor-intensive and require skilled technicians.
• Regulatory complexities: Compliance with various regulations and standards for blood transfusion practices can pose challenges for laboratories.

Emerging Trends in U.S. Blood Group Typing

• Automated blood typing systems: Automation of blood typing processes reduces errors, improves efficiency, and increases throughput.
• Multiplex assays: Multiplex platforms allow for simultaneous testing of multiple blood group antigens, reducing sample requirements and turnaround time.
• NGS-based blood typing: NGS technologies offer high-resolution and comprehensive blood group profiling, enabling the detection of rare or complex antigens.

Growth Catalysts in the U.S. Blood Group Typing Industry

• Growing aging population: An increasing elderly population with higher healthcare needs drives the demand for blood transfusions and blood group typing services.
• Rising healthcare awareness: Increased public awareness about the importance of blood typing in transfusions and organ transplantation fosters market growth.
• Collaboration and partnerships: Partnerships between manufacturers and healthcare providers facilitate the development and adoption of innovative blood typing technologies.

Market Segmentation: U.S. Blood Group Typing Analysis

Product:

• Instruments
• Reagents & Kits

Test Type:

• ABO Tests
• Antigen Typing
• Antibody Screening
• Cross-matching Tests
• HLA Typing

Technique:

• Serology Tests
• Molecular Tests

End-user:

• Hospital-based Laboratories
• Independent Laboratories & Blood Banks

Leading Players in the U.S. Blood Group Typing Market

• Quotient Limited 
• CareDx Inc.
• Agena Bioscience, Inc. 
• DIAGAST 
• Illumina, Inc.

• Grifols, S.A. 

   

Significant Developments in the U.S. Blood Group Typing Sector

• July 2022: Quotient Limited and InfYnity Biomarkers signed an agreement to expand MosaiQ's infectious disease portfolio, including blood screening tests.
• March 2021: Grifols S.A. installed a DG Reader Net semi-automated analyzer at ThedaCare Medical Center-Wild Rose in Wisconsin, U.S.
• October 2020: Lorne Laboratories, a producer of blood grouping reagents and diagnostic test kits, was acquired by Calibre Scientific.

Comprehensive Coverage U.S. Blood Group Typing Market Report

Our comprehensive U.S. Blood Group Typing Market Report provides:

• Detailed analysis of market size, growth drivers, challenges, and trends
• In-depth segmentation based on product, test type, technique, and end-user
• Profiles of leading players, including company overview, product portfolios, and financial performance
• Examination of key industry developments, such as mergers, acquisitions, and product launches
• Regional analysis of the U.S. blood group typing market

Regional Insight

The U.S. continues to dominate the global blood group typing market, capturing a commanding share. Its well-established healthcare infrastructure, high prevalence of blood-related disorders, and ongoing advancements in medical technology contribute to its leading position.

Other notable regional markets include Europe, Asia-Pacific, and the Rest of the World. Europe holds a substantial share, driven by factors such as a large and aging population, increasing healthcare expenditure, and a rising demand for personalized medicine.

Asia-Pacific, particularly China and India, is emerging as a promising market due to its growing population, rising healthcare awareness, and government initiatives to improve healthcare infrastructure. The Rest of the World, which includes regions such as Latin America, the Middle East, and Africa, also presents opportunities for growth, albeit at a more gradual pace.